The ability of the CD44 adhesion molecule to interact with its ligand hyalu
ronic acid (HA) is tightly regulated. CD44-positive mouse LB lymphoma cells
are unable to bind HA unless activated by the tumor promoter phorbol 12-my
ristate 13-acetate (PMA). PMA causes a dose-dependent increase in both CD44
expression level and HA-binding capacity, with the binding of HA observed
only above a threshold amount of CD44 molecules. This induction of HA-bindi
ng as well as the increase in CD44 expression are prevented by cycloheximid
e, suggesting a requirement for new additional CD44 molecules on the cell s
urface and/or cooperating proteins. In the present study, we have investiga
ted which of the signal transduction pathways activated by PMA leads to the
increased CD44 expression with subsequent acquisition of HA-binding capaci
ty. By comparing the influence of each inhibitory agent on PMA-activated LB
lymphoma cells versus that on a constitutive HA-binder cell line derived f
rom LB cells (designated HA9 cells), we could distinguish between an effect
on the PMA-activation phase and a one on the HA-binding phase. Our data sh
ow that the PMA-induced HA-binding could not be blocked by agents inhibitin
g protein kinase C (PKC) (staurosporine, sphingosine, polymyxin B, querceti
n) or genestein, an inhibitor of tyrosine protein kinases. However, this PM
A response was strongly inhibited by calmodulin antagonists (chlorpromazine
, trifluoperazine, W-7) and the calcium blocker verapamil. The calmodulin a
ntagonists inhibited the PMA-induced increase in CD44 expression on LB cell
s, but had no influence on the ability of the constitutive HA-binder HA9 ce
ll line to interact with HA, indicating an effect on the PMA induction phas
e rather than on the binding itself. Verapamil also blocked the PMA-induced
increase in CD44 expression on LB cells, but in addition it slightly reduc
ed the ability of the HA9 cells to bind HA without affecting their CD44 exp
ression level, In conclusion, our data suggest that CD44 activation by PMA
is calcium and calmodulin dependent, rather than mediated by protein kinase
C.